Healthcare Markets
Healthcare Markets
Encouraging Competition and Efficiency
Our researchers explore strategies for a patient-centered marketplace that lowers medical costs while expanding access to quality care.
Featured Article
U.S. Consumers Overpay for Generic Drugs
Growing evidence indicates U.S. consumers and employers and the government often overpay for generics as pharmacy benefit managers (PBMs) and their affiliated insurer companies game opaque and arcane pricing practices to pad profits.
Experts:
Erin Trish, Karen Van Nuys, Robert Popovian
Featured Research
Exploding Popularity of Ozempic, Wegovy Among Privately Insured Patients May Worsen Disparities
Publicly insured individuals who are most likely to benefit from new drugs for diabetes and obesity may be less likely to get them than those with private insurance.